Arkolith/Insider Trading/INDV/Form 4

Burris Jeffrey W

Chief Legal OfficerIndivior Pharmaceuticals, Inc. (INDV) · full profile →Form 4 · filed Mar 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Option exercise(M)80K——108K
Mar 3, 2026Tax withholding(F)36K$31.98$1.2M72K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2026Option exercise(M)104K——0

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001484322-26-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML